Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Clover Health Stock Is Still Risky, But Speculators Could Consider It

By Josh Enomoto, InvestorPlace Contributor

While conservative investors will want to stay away from risky CLOV stock, speculators can play its recent news item.

4 Stocks to Sell (and 4 to Buy) Amid Facebook’s Whistleblower Scandal

By Josh Enomoto, InvestorPlace Contributor

With the Facebook scandal possibly forcing a greater response by social media, here are the stocks to sell (and buy) from the PR crisis.

Joby Aviation’s Innovation Doesn’t Merit Taking a ‘Flyer’ on JOBY Stock

By Josh Enomoto, InvestorPlace Contributor

While JOBY stock may offer an investment into the future of personal air mobility, you shouldn’t ignore its major risks.

7 Best Blue-Chip Stocks to Buy as China Shakes the Market

By Josh Enomoto, InvestorPlace Contributor

Although the China Evergrande crisis sent a wave of worries to the market, these blue-chip stocks may offer a viable discount to investors.

Hippo Holdings Suffrers From Much More Than Generalized SPAC Exhaustion

By Josh Enomoto, InvestorPlace Contributor

While HIPO stock is connected to the relevant tech-based insurance services sector, economic challenges pose serious concerns.

Load More